pet care
A data‑driven walk‑through of Elanco Animal Health’s Q1 2026 earnings report and how its revenue and EPS trends compare to the broader pet health industry and biotech sector, - contrarian
Elanco Animal Health posted a 17% year-over-year revenue increase in Q1 2026, topping the pet health industry average by five points. The surge came after a bruising Q4 loss, signalling a possible inflection point for the company and its investors. Medical Disclaimer: This article is for informational purposes only and